ep preview small cap
full comment requir non-u analyst conflict disclosur
pleas click link
goodman make gud great initi outperform
downgrad sector perform
downgrad sector perform
rais ep fuel outlook
impress beat strong top-line margin
like overshadow takeda/potenti acquisit situat
solid neg surpris
brazil surpris soliri ip break add headwind soliri row rev
announc miss divestitur sound provid comp evhc
show promis increas smn protein level await detail
preview uranium market inact sever catalyst watch
dunkin go outperform
expect decent quarter upsid guidanc preview
top question ahead investor day
fre termin deal vigor defend stock link litig
price prior day market close estimate unless otherwis note
takeaway new york
canadian reit reoc
sale /china posit eu
feedback across world
updat loan week
mackay takeaway
nyc day
midstream energi check
news nashvil
compani continu move forward execut strategi
modest step forward re-affirmed guidanc
busi usual rais
return capit gem
clean rais readi
steadili move profit needl higher
ep solid quarter impress return posit outlook remain
let talk strateg option given strong fundament
migrain ms ibd car-t dmd/sma cf nash mm depress
report calendar estim date confer call detail
 /china sale grew march eu sale declin y/i difficult comp
week april
weekli perspect healthcar industri compani news valuat updat
inject debat aesthet toxin/cellulit focu
cgrp data point cgrp debat read agn teva
continu digest learn last week
top investor question week payment processor servic
 of daili summari
 spak thought china
cheat sheet
specialti pharma
focus week
lift us defens export
week ahead busi week med-tech
primer invest
connector sensor market
news nashvil
ew report result
thought opportun connector sensor market
find research
insight www rbcinsightresearch com global research destin web contact capit market sale
repres access global research site use ipad app research
valu cad unless otherwis note
goodman make gud great initi outperform
initi coverag knight therapeut outperform rate
target knight manag transform last compani paladin
lab success stori conserv accret pharma acquisit
manag appli approach knight share trade
near book valu see attract risk/reward profil recommend
share purchas investor seek long-term price appreci
build paladin knight form carve-out paladin
lab like paladin knight focu licens acquisit late-
stage pharma product canada select intern market knight ceo
jonathan goodman led paladin decad growth share go
strategi employ knight see
strong potenti repeat success
spec pharma exposur low-risk model mr goodman ms samira
sakhia cfo instrument paladin success tenur paladin
limit transact ebitda never use debt consist
accret transact give us confid manag abil execut
knight said acknowledg signific valu creation could take
time
uniqu busi model compani gener return capit lend
invest life scienc firm use relationship sourc
licens opportun addit focu non-u market reduc
competit pressur knight may face
risk-reward attract today note large-scal deal may
occur near-term believ downsid limit unlik share
trade book valu current think upsid current level
share move toward paladin histor price-to-book
price target base premium book valu price target
base price-to-book multipl appli project year-end book valu
downgrad sector perform
think beat/rais cycl continu see risk moder
beat due lap comp success product cycl ii slow america
growth iii potenti build competit impact salesforc essenti iv
gdpr legisl valuat year median take sector
perform pt
downgrad sector perform move pt
think beat/rais cycl continu also believ valuat reflect
much optim
find harder underwrit top line re-acceler given exist
penetr growth stack mean lowest hang fruit captur ii
deceler america region despit product cycl iii potenti competit
impact salesforc essenti iv potenti risk gdpr legisl
light issu valuat year averag
move sector perform
valu usd unless otherwis note
valu usd unless otherwis note
downgrad sector perform
downgrad payloc sector perform move pt
think mid-market payrol space go becom competit
next month hint alreadi begin show addit
think om expans may constrain light chang sale product
downgrad payloc sector perform move pt
think mid-market employe payrol space go
get competit almost estimate adp mid-market custom
attrit absorb cloud payrol vendor estim
addit revenu attrit rate stabil suggest expand
see moder beat vs guidanc top line moder margin
expans due reinvest sale product may
increas optic profit due capit sale commiss
impact
rais ep fuel outlook
bhge energi conglomer exposur energi valu chain
rate bhge outperform driven improv outlook book synergi
execut within oilfield servic return cash sharehold bhge
elbow way larg cap of club good posit
outperform oih phase energi cycl
valu usd unless otherwis note
valu usd unless otherwis note
rais ep boost price target
primari driver upsid ep revis robust margin outlook
tp busi driven lesser extent oilfield servic
oilfield equip segment correspond ebitda
ep remain street ep
impress beat strong top-line margin
continu strength segment drove anoth beat expect similar
trend result guidanc rais report increas
estim guidanc rais price target
segment exceed intern expect post anoth
impress beat
vita perform continu reflect solid volum growth margin
expans mix shift tight cost manag roto-root also
see strong top-line growth drive impress margin expans hold
line oper cost
manag anticip posit theme continu left
guidanc unchang suggest like increas later year
report larg in-lin result site rental revenu modestli better
expect manag rais guidanc mla sign
maintain organ growth expect firstnet impact expect
start believ macro tower leas gradual acceler
t-mobil activ fuel outsourc portion small-cel
report larg in-lin result site rental revenu
exclud non-cash benefit mla modestli
better rbc/consensu estim respect adjust
ebitda excl mla impact affo/shar
